Integration without the surprises.
Your RTSM is live. Your EDC is live. The seam between them is where trials stall — and it's rarely anyone's job. I'm the independent specialist who has sat on both sides of that API, turning vendor specs into working data flows before they reach UAT.
The integration seam is no one's primary responsibility.
Subject registration, randomization, stratification, dispensation, dosing, visit milestones — it all flows between RTSM and EDC. When that flow breaks, the consequences are tangible: enrollment delays, reconciliation work, protocol deviations, regulatory risk.
The RTSM vendor owns their side
Scoped narrowly to their platform, and not incentivized to go beyond contractual obligations.
The EDC vendor owns theirs
Same story, opposite end of the pipe. Each vendor is right about their half and silent on the join.
The seam belongs to no one
So it lands on data management or a project manager who lacks integration-specific, vendor-side depth. That's the gap I close.
Productized, project-based, scoped to the seam.
Six focused engagements — from a one-week audit to an ongoing portfolio retainer. Every one stays on the integration layer between RTSM and EDC. I don't implement or configure the platforms themselves.
DTS Pre-UAT Audit
An independent review of your DTS for completeness, mapping accuracy, error handling, and regulatory readiness — before UAT, while issues are still cheap to fix.
DTS Deep Review + UAT Support
Line-by-line specification review plus UAT test-script support — independent QA on a vendor-built integration.
UAT Planning & Test Strategy
Integration-specific test plan, script development, defect triage, and a go-live readiness call — catching what vendor self-UAT tends to miss.
Mid-Study Change Support
Assessment and remediation when a protocol amendment changes the integration mid-study — the scenario vendors support least.
Integration Troubleshooting
Root-cause analysis for an active integration failure, with fixes coordinated across vendors and a remediation plan you can act on.
Monthly Retainer
Ongoing integration support across a portfolio of studies — the steady hand once you have three or more active trials.
Built from inside the RTSM vendor.
Five years vendor-side at Suvoda — across oncology, CNS, and rare disease — means knowing where cross-vendor specs break down, where UAT gets compressed, and where defects surface late. That's not a slide; it's the work I delivered.
Vendor-side depth
From Technical Consultant to Integration Solutions Lead to RTSM Systems Delivery Lead. I've designed and shipped the integrations now keeping your team up at night.
Vendor-neutral perspective
No platform affiliation. I work across Suvoda, Medidata Rave, Veeva Vault EDC, Signant, and cross-vendor combinations. Findings reflect the study's needs, not a vendor relationship.
Focused scope
Exclusively RTSM–EDC integration. Not a generalist clinical consultant, not a CRO, not an RTSM implementer. The integration seam is the only thing on the table.
Fixed fees, not hours
Project-based pricing gives cost certainty and rewards expertise over time tracked. You know the number before the work starts.
Five steps. No vendor theatre.
I sit alongside the work, not in front of it — your team keeps the relationships and the credit. Weekly updates, issues escalated early, not at go-live.
Discovery
A free 30-minute call to understand your integration challenge, platform combination, and study timeline.
Scoping
Deliverables, timeline, and a fixed fee, defined clearly. SOW delivered for signature — typically within 48 hours.
Kickoff
Alignment with your data management, CRO, and vendor teams. Confirm document access and stakeholder contacts.
Execution
The work gets delivered. Weekly status updates. Issues raised early, while there's still time to act on them.
Close
Final deliverables reviewed and accepted. A debrief call, and a look at any ongoing needs.
Sponsors and CROs who can't afford a silent seam.
Small biotech
Phase I–III trials with lean internal data management. You rely on CROs for technology but need oversight on integration quality. One to ten active studies.
Mid-size pharma
Larger portfolios and experienced data managers who understand the need but lack bandwidth or vendor-side experience to own the seam.
CROs
Managing integrations on behalf of sponsors — especially unfamiliar platform combinations or complex designs. White-label, referral, or retainer.
Core integration principles are platform-agnostic; the depth is in the details across:
Get ahead of the seam before UAT.
The DTS Pre-UAT Audit is the most common starting point — a low-risk way to surface integration issues before they reach testing. Let's spend 30 minutes on where your study stands.